首页> 美国卫生研究院文献>Current Controlled Trials in Cardiovascular Medicine >Rationale and design of the ADDITION-Leicester study a systematic screening programme and Randomised Controlled Trial of multi-factorial cardiovascular risk intervention in people with Type 2 Diabetes Mellitus detected by screening
【2h】

Rationale and design of the ADDITION-Leicester study a systematic screening programme and Randomised Controlled Trial of multi-factorial cardiovascular risk intervention in people with Type 2 Diabetes Mellitus detected by screening

机译:通过筛查发现的2型糖尿病患者的ADDITION-Leicester研究系统筛查程序和多因素心血管风险干预措施的随机对照试验的原理和设计

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundEarlier diagnosis followed by multi-factorial cardiovascular risk intervention may improve outcomes in Type 2 Diabetes Mellitus (T2DM). Latent phase identification through screening requires structured, appropriately targeted population-based approaches. Providers responsible for implementing screening policy await evidence of clinical and cost effectiveness from randomised intervention trials in screen-detected T2DM cases. UK South Asians are at particularly high risk of abnormal glucose tolerance and T2DM. To be effective national screening programmes must achieve good coverage across the population by identifying barriers to the detection of disease and adapting to the delivery of earlier care. Here we describe the rationale and methods of a systematic community screening programme and randomised controlled trial of cardiovascular risk management within a UK multiethnic setting (ADDITION-Leicester).
机译:背景早期诊断,然后进行多因素心血管风险干预,可能会改善2型糖尿病(T2DM)的预后。通过筛选识别潜伏期需要结构化,针对性强的针对人群的方法。负责实施筛查政策的提供者正在等待在筛查到的T2DM病例中进行随机干预试验的临床证据和成本效益证据。英国南亚人异常糖耐量异常和2型糖尿病的风险特别高。为实现有效的国家筛查计划,必须通过确定发现疾病的障碍并适应提供早期护理的方式,在整个人群中实现良好的覆盖率。在这里,我们描述了在英国多种族环境下(ADDITION-Leicester)进行的系统性社区筛查程序和心血管疾病风险管理的随机对照试验的原理和方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号